Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
03/2005
03/17/2005WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs
03/17/2005US20050059831 4-Aryloxy-2-buten-4-olides prepared by reacting masked mucohalic acid with a substituted phenol in presence of base; chemical intermediates for drug synthesis
03/17/2005US20050059830 Novel lactone compounds
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059659 Carotenoid analogs or derivatives for controlling C-reactive protein levels
03/17/2005US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005US20050059635 Astaxanthin, beta-carotene, zeanthin, canthaxanthin
03/17/2005US20050056812 Fluorinated heterocycles and their use in liquid-crystal mixtures
03/17/2005CA2537958A1 Process for the production of mycophenolate mofetil
03/17/2005CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005CA2536975A1 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/16/2005EP1514540A1 Calcium-containing tissue strengthening agents and use thereof
03/16/2005EP1513959A2 Antiviral inhibitions of capsid proteins
03/16/2005EP1513824A1 Furancarboxamides
03/16/2005EP1417194B1 Method for producing maleic anhydride
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP1028935B1 Fluorinated derivatives of phenanthrene and the utilization thereof in liquid crystal mixtures
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1594303A Method for separation purification of sclareolide from synthetic sclareol composites
03/16/2005CN1594302A Process for continuous preparation of trimellitic anhydride by step catalytic oxidation process
03/16/2005CN1594301A 3-substituted phenyl-benzo furanone stabilizer and preparing process thereof
03/16/2005CN1594247A Yew genus plant extract and its extraction method and application
03/16/2005CN1593837A Novel purpose of 4-(4-methyl-3-pentenyl)-4-cyclohexene-1, 2-diacid anhydride
03/16/2005CN1192999C Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
03/15/2005US6867321 Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof
03/15/2005US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867296 Useful as a monomer in the manufacture of polymers and copolymers, especially polyester polymers and copolymers
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity
03/15/2005US6867171 Liquids; easy to handle; paper chemicals, lubricants, dis-persants, detergents
03/15/2005US6867161 Titanium catalyst and organotitanium reacting reagent, production thereof, and reaction thereby
03/10/2005WO2005021527A2 Process for the asymmetric hydrogenation of beta-amino ketones
03/10/2005WO2005021496A2 Synthesis of derivatives of ginkgolide c
03/10/2005WO2005021487A1 Cathepsin inhibitors
03/10/2005WO2005020917A2 Ophthalmic compositions for treating ocular hypertension
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004098284A3 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
03/10/2005US20050054721 3-Aryl-4-Hydroxyfuranone compounds and the human and animal health use thereof
03/10/2005US20050054720 Saururus cernuus compounds that inhibit cellular responses to hypoxia
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054677 Process for preparing amine-substituted benzofurans
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054536 Reacting an cyanoacrylate compound with amidine compound
03/10/2005US20050053714 Brassica seeds
03/10/2005US20050053652 Pharmaceutical composition containing citalopram
03/10/2005CA2537119A1 Ophthalmic compositions for treating ocular hypertension
03/10/2005CA2535366A1 Cathepsin inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512678A1 Process for preparing optically active nitro compounds and cyano compounds
03/09/2005EP1511788A1 Method for producing polytetrahydrofurane with low colour indices
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511478A2 Triptolide derivatives for modulation of apoptosis and immunosuppression
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1592726A Optical dividing method for sclare lactone precursor
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1590554A Ketone compound and its preparation method and application
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/09/2005CN1590383A Rod sage root extract and making method of its preparation
03/09/2005CN1590382A Method of preparing gamma butyrolactone by 1, 4-butanediol dehydrogenation
03/09/2005CN1590381A Method of preparing gamma butyrolactone and tetrahydropyrane from 1, 4-butanediol
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864394 Method for producing ketones from carboxylic acid anhydrides
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864379 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
03/08/2005US6864376 Cyclization of ketogulonic acid
03/08/2005US6864285 Hypotensive agents; antihistamines; immunology moderators; antiinflammatory agents
03/08/2005US6864284 Ascorbic acid compounds, methods of synthesis and application use thereof
03/08/2005US6864283 Marine extracts; analogs of the spisulosine family
03/03/2005WO2005019196A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them
03/03/2005WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
03/03/2005WO2005019151A1 Ppar modulators
03/03/2005WO2005018799A1 Method and reactor for production of hydroxymethylfurfural
03/03/2005WO2004113315A3 Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
03/03/2005WO2004094398A3 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2003050102A8 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use
03/03/2005US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/03/2005US20050049418 such as 3-benzyl-1-methoxy-4,5-dimethylimidazolium iodide; by-product inhibition; for recycling polyesters and polyamides
03/03/2005US20050049302 Reacting p-amido or carbamyl-alkoxybenzene with 2-bromohexanoyl halide and aluminum halide; cyclizing, dehydrating and nitrogen deprotecting; sulfoamidation and friedel crafts acylation; lower cost; easily purified, storage stable claimed intermediates
03/03/2005US20050049300 Converting the carboxyl group of a thromboxane ligand to an amide or amine to obtain an ocular hypotensive agent; mimic the vasoconstrictor properties of thromboxane A2 and its endoperoxide precursors, without causing concomitant platelet aggregation; post-surgery and post laser treatment
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 472